Breaking down Eli Lilly's solid Q4 earnings, and the company's outlook for 2013, with its CFO Derica Rice. "From a regulatory standpoint, we have really seen a harmonization between the U.S. and Europe," he says.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT